Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis

Intensive Care Medicine

Volumn 43, Issue 6, 2017, Pages 785-794

  Ehrmann, Stephan ^a,b   Quartin, Andrew ^c,d   Hobbs, Brian P ^e   Robert Edan, Vincent ^f   Cely, Cynthia ^c,d   Bell, Cynthia ^g   Lyons, Genevieve ^e   Pham, Tai ^h,i,j   Schein, Roland ^c,d   Geng, Yimin ^e   Lakhal, Karim ^f   Ng, Chaan S ^e  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f CHU de Nantes   (France)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

ⁱ PARIS DESCARTES UNIVERSITY   (France)

^j ST MICHAEL'S HOSPITAL   (Canada)

more..

Author keywords

Contrast media (MeSH: D003287); Drug related side effects and adverse reactions (MeSH D064420); Intensive care units (MeSH D007362); Percutaneous coronary interventions (MeSH: D062645); Tomography scanners, X ray computed (MeSH: D015898)

Indexed keywords

CREATININE; IODINATED CONTRAST MEDIUM; CONTRAST MEDIUM; IODINE;

ACUTE KIDNEY FAILURE; ARTICLE; BAYES THEOREM; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; FLORIDA; FRANCE; HUMAN; META ANALYSIS; MORTALITY RATE; PHYSICIAN; QUANTITATIVE ANALYSIS; RENAL REPLACEMENT THERAPY; SYSTEMATIC REVIEW; TEXAS; ADULT; AGED; COHORT ANALYSIS; FEMALE; HEMODIALYSIS; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; ODDS RATIO; PROCEDURES; PROPENSITY SCORE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; X-RAY COMPUTED TOMOGRAPHY;

ACUTE KIDNEY INJURY; ADMINISTRATION, INTRAVENOUS; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; COHORT STUDIES; CONTRAST MEDIA; CRITICAL CARE; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; IODINE; MALE; MIDDLE AGED; ODDS RATIO; PROPENSITY SCORE; RENAL DIALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85012930298     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-017-4700-9     Document Type: Article

References (40)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:S1–S138. doi:10.1038/kisup.2012.1
2. Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, Laghi F, Magder S, Papazian L, Pelosi P, Polderman KH, ATS, ERS, ESICM, SCCM, SRLF Ad Hoc Committee on Acute Renal Failure (2010) An Official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 181:1128–1155. doi:10.1164/rccm.200711-1664ST
3. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S (1991) Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 157:49–58. doi:10.2214/ajr.157.1.2048539
4. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399. doi:10.1016/j.jacc.2004.06.068
5. Brown JR, DeVries JT, Piper WD, Robb JF, Hearne MJ, Ver Lee PM, Kellet MA, Watkins MW, Ryan TJ, Silver MT, Ross CS, MacKenzie TA, O’Connor GT, Malenka DJ, Northern New England Cardiovascular Disease Study Group (2008) Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J 155:260–266. doi:10.1016/j.ahj.2007.10.007
6. McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH, Kallmes DF (2013) Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 267:119–128. doi:10.1148/radiol.12121460
7. McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271:65–73. doi:10.1148/radiol.13130775
8. McDonald RJ, McDonald JS, Carter RE, Hartman RP, Katzberg RW, Kallmes DF, Williamson EE (2014) Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273:714–725. doi:10.1148/radiol.14132418
9. Rashid AH, Brieva JL, Stokes B (2009) Incidence of contrast-induced nephropathy in intensive care patients undergoing computerized tomography and prevalence of risk factors. Anaesth Intensive Care 37:968–975
10. Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J (2011) Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 37:1921–1931. doi:10.1007/s00134-011-2389-8
11. Lakhal K, Ehrmann S, Chaari A, Laissy JP, Régnier B, Wolff M, Pajot O (2011) Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care 26:593–599. doi:10.1016/j.jcrc.2011.05.010
12. Persson PB, Hansell P, Liss P (2005) Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68:14–22. doi:10.1038/sj.ki.5001887
13. Andreucci M, Solomon R, Tasanarong A (2014) Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int 214:741018. doi:10.1155/2014/741018
14. Fernandes SM, Martins DM, da Fonseca CD, Watanabe M, de Vattimo MF (2016) Impact of iodinated contrast on renal function and hemodynamics in rats with chronic hyperglycemia and chronic kidney disease. Biomed Res Int 2016:3019410. doi:10.1155/2016/3019410
15. Rouse RL, Stewart SR, Thompson KL, Zhang J (2013) Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media. Toxicol Pathol 41:662–680. doi:10.1177/0192623312464122
16. Heyman SN, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 3:288–296. doi:10.2215/CJN.02600607
17. Vandenberghe W, De Corte W, Hoste EA (2014) Contrast-associated AKI in the critically ill: relevant or irrelevant? Curr Opin Crit Care 20:596–605. doi:10.1097/MCC.0000000000000156
18. Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF, PRISMA-IPD Development Group (2015) Preferred reporting items for a systematic review and meta-analysis of individual participant data. The PRISMA-IPD statement. JAMA 313:1657–1665. doi:10.1001/jama.2015.3656
19. Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. doi:10.1186/1472-6947-7-16
20. Ruppert D, Wand MP, Carroll RJ (2003) Semiparametric regression. Cambridge University Press, New York
21. Hobbs BP, Thall PF, Lin SH (2016) Bayesian Group sequential clinical trial design using total toxicity burden and progression-free survival. J R Stat Soc Ser C Appl Stat 65:273–297. doi:10.1111/rssc.12117
22. Spiegelhalter DJ, Abrams KR, Myles JP (2003) Evidence synthesis. In: Spiegelhalter DJ, Abrams KR, Myles JP (eds) Bayesian approaches to clinical trials and health-care evaluation. Wiley, Chichester, pp 267–299
23. Morita S, Thall PF, Müller P (2008) Determining the effective sample size of a parametric prior. Biometrics 64:595–602. doi:10.1111/j.1541-0420.2007.00888.x
24. Huber W, Jeschke B, Page M, Weiss W, Salmhofer H, Schweigart U, Ilgmann K, Reichenberger J, Neu B, Classen M (2001) Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk. Intensive Care Med 27:1200–1209
25. Haveman JW, Gansevoort RT, Bongaerts AH, Nijsten MW (2006) Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med 32:1199–1205. doi:10.1007/s00134-006-0198-2
26. Polena S, Yang S, Alam R, Gricius J, Gupta JR, Badalova N, Chuang P, Gintautas J, Conetta R (2005) Nephropathy in critically ill patients without preexisting renal disease. Proc West Pharmacol Soc 48:134–135
27. Tremblay LN, Tien H, Hamilton P, Brenneman FD, Rizoli SB, Sharkey PW, Chu P, Rozycki GS (2005) Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. J Trauma 59:1162–1166
28. Oleinik A, Romero JM, Schwab K, Lev MH, Jhawar N, Delgado Almandoz JE, Smith EE, Greenberg SM, Rosand J, Goldstein JN (2009) CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 40:2393–2397. doi:10.1161/STROKEAHA.108.546127
29. McGillicuddy EA, Schuster KM, Kaplan LJ, Maung AA, Lui FY, Maerz LL, Johnson DC, Davis KA (2010) Contrast-induced nephropathy in elderly trauma patients. J Trauma 68:294–297. doi:10.1097/TA.0b013e3181cf7e40
30. Ng CS, Shaw AD, Bell CS, Samuels JA (2010) Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol 195:414–422. doi:10.2214/AJR.09.4150
31. Cely CM, Schein RM, Quartin AA (2012) Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care 16:R67. doi:10.1186/cc11317
32. Kim DY, Kobayashi L, Costantini TW, Chang D, Fortlage D, Curry T, Wynn S, Doucet J, Bansal V, Coimbra R (2012) Is contrast exposure safe among the highest risk trauma patients? J Trauma Acute Care Surg 72:61–66. doi:10.1097/TA.0b013e31823f36e0
33. Ehrmann S, Badin J, Savath L, Pajot O, Garot D, Pham T, Capdevila X, Perrotin D, Lakhal K (2013) Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med 41:1017–1026. doi:10.1097/CCM.0b013e318275871a
34. Christ M, Auenmüller KI, Amirie S, Brand M, Sasko BM, Trappe HJ (2016) Acute kidney injury and renal replacement therapy in victims from out-of-hospital cardiac arrest with administration of contrast agent. Herzschrittmarcherther Elektrophysiol 27:6–14. doi:10.1007/s00399-015-0410-6
35. Gao J, Zhang M, Fang G, Ye L, Tang W (2005) Risk and harm of contrast induced nephropathy in critically ill patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 27:366–370. doi:10.3760/cma.j.issn.2095-4352.2015.05.009
36. Wilhelm-Leen E, Montez-Rath ME, Chertow G (2016) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28. doi:10.1681/ASN.2016010021
37. Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ, Hutfless S, Bass EB (2016) Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 164:406–416. doi:10.7326/M15-1456
38. Eng J, Wilson RF, Subramaniam RM, Zhang A, Suarez-Cuervo C, Turban S, Choi MJ, Sherrod C, Hutfless S, Lyoha EE, Bass EB (2016) Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 164:417–424. doi:10.7326/M15-1402
39. Salmon-Gandonnière C, Benz-de-Bretagne I, Mercier E, Joret A, Halimi JM, Ehrmann S, Barin-Le Guellec C (2016) Iohexol clearance in unstable critically ill patients: a tool to assess glomerular filtration rate. Clin Chem Lab Med 54:1777–1786. doi:10.1515/cclm-2015-1202
40. Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Gitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–999. doi:10.1164/rccm.201401-0077OC